R
Rodney H. Falk
Researcher at Brigham and Women's Hospital
Publications - 286
Citations - 22724
Rodney H. Falk is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Amyloidosis & Cardiac amyloidosis. The author has an hindex of 76, co-authored 271 publications receiving 19735 citations. Previous affiliations of Rodney H. Falk include Wake Forest University & Boston Medical Center.
Papers
More filters
Journal ArticleDOI
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Julian D. Gillmore,Mathew S. Maurer,Rodney H. Falk,Giampaolo Merlini,Thibaud Damy,Angela Dispenzieri,Ashutosh D. Wechalekar,John L. Berk,John L. Berk,Candida Cristina Quarta,Martha Grogan,Helen J. Lachmann,Sabahat Bokhari,Adam Castano,Sharmila Dorbala,Geoff B. Johnson,Andor W. J. M. Glaudemans,Tamer Rezk,Marianna Fontana,Giovanni Palladini,Paolo Milani,P.L Guidalotti,Katarina Flatman,Thirusha Lane,Frederick W. Vonberg,Carol J. Whelan,James C. Moon,Frederick L. Ruberg,Frederick L. Ruberg,Edward J. Miller,David F. Hutt,Bouke P. C. Hazenberg,Claudio Rapezzi,Philip N. Hawkins +33 more
TL;DR: Bone scintigraphy enables the diagnosis of cardiac ATTR amyloidosis to be made reliably without the need for histology in patients who do not have a monoclonal gammopathy, and proposes noninvasive diagnostic criteria that are applicable to the majority of patients with this disease.
Journal ArticleDOI
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz,Raymond L. Comenzo,Rodney H. Falk,Jean Paul Fermand,Bouke P. C. Hazenberg,Philip N. Hawkins,Giampaolo Merlini,Philippe Moreau,Pierre Ronco,Vaishali Sanchorawala,Orhan Sezer,Alan Solomon,Giles Grateau +12 more
TL;DR: A consensus panel was convened comprising 13 specialists actively involved in the treatment of patients with amyloidosis, and a consensus was developed defining each organ involved and the criteria for response.
Journal ArticleDOI
The Systemic Amyloidoses
TL;DR: Amyloidosis is not a single disease but a term for diseases that share a common feature: the extracellular deposition of pathologic insoluble fibrillar proteins in organs and tissues.
Journal ArticleDOI
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Randomised Clinical Trial
Joseph L. Blackshear,Vickie S. Baker,F. Rubino,Robert E. Safford,Gary E. Lane,T. Flipse,J. Malouf,Randall C. Thompson,Richard Webel,Greg C. Flaker,L. Young,David C Hess,G. Friedman,R. Burger,John H. McAnulty,Bruce M. Coull,Christy Marchant,J. Timberg,C. Janzik,G. Giraud,B. Halperin,J. Kron,M. Wynn,M. Raitt,David C. Anderson,Richard W. Asinger,S. M. Newburg,J. Fifield,S. R. Bundlie,Richard L. Koller,R. D. Tarrel,C. Dick,J. M. Haugland,C. R. Jorgensen,Anne D. Leonard,Merrill C. Kanter,Diane H. Solomon,Miguel Zabalgoitia,D. Mego,John E. Carter,S. Y. Boyd,Bradley S. Boop,D. LaLonde,R. Modlin,William R. Logan,B. J. Green,William P. Hamilton,L. Mezei,S. Riggio,George Feldman,Arthur D. Hayward,R. Strauss,W. Anderson,J. Grover,M. McKenzie,P. Hart-McArthur,M. Gramberg,H. Houston,Jonathan L. Halperin,E. B. Rothauf,Jesse Weinberger,Martin E. Goldman,Andreas Laupacis,K. L. Chan,P. Bourque,J. Biggs,A. Ives,William M. Feinberg,Karl B. Kern,Gregory D. Pennock,Paul E. Fenster,B. J. Huerta,J. Ohm,Howard C. Dittrich,C. Kerridge,W. Keen,M. Swenson,Stephen L. Kopecky,Scott C. Litin,David O. Wiebers,Anne E. Holland,Ronald D. Brown,B. K. Khandheria,I. Meissner,K. R. Tucker,Robert M. Rothbart,J. Torelli,J. Schmidt,D. Murray,R. S. Ruzich,H. Loutfi,Christopher P. Appleton,T. Ingall,L. Carlson,D. Wilson,M. Dunn,B. Nolte,C. Edwards,A. Dick,L. A. Price,Denise L. Janosik,P. Bjerregaard,A. Quattromani,L. Schiller,Arthur J. Labovitz,C. Burch,B. J. Parks,D. Thompson,L. Berarducci,S. Carey,A. Vigil,Rodney H. Falk,N. Battinelli,M. McNeil,R. Davidoff,Sheilah Bernard,P. Bergethon,L. Fiori,Gregory W. Albers,E. Atwood,J. Clark,D. Tong,Midori A. Yenari,V. Froelicker,H. Lutsep,N. H. Hock,S. Quaglietti,S. Kemp,M. A. Alpert,J. F. Rothrock,C. H. Hupp,C. V. Massey,W. J. Hamilton,V. T. Miller,J. Fox,RichardA. Kronmal,Ruth McBride,E. Nasco,Lesly A. Pearce,K. Fletcher,Jodi Koehler,Robert G. Hart,David G. Sherman,R. L. Talbert,P. A. Heberling,C. Kajzer,EG Bovill,D. Geffken,E. Cornell,S. Nightingale,S. P. Kelsy,David E. Levy,J. D. Marsh,K. M.A. Welch,John R. Marler,M. D. Walker +155 more
TL;DR: Low-intensity, fixed-dose warfarin plus aspirin in this regimen is insufficient for stroke prevention in patients with non-valvular AF at high-risk for thromboembolism; adjusted-doseWarfarin (target INR 2.0-3.0) importantly reduces stroke for high- risk patients.
Journal ArticleDOI
Diagnosis and Management of the Cardiac Amyloidoses
TL;DR: The purpose of this review is to familiarize the reader with the clinical features of amyloidosis and to address the approach to the patient with this disease, focusing on the various types of ameloidosis, their prognosis and treatment.